Select for export Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopha.2023.115775 PubMed 37944438 Copy citation Copy BibTeX Unknown journal 2023-11-06 Madrid-Gambin F, Fabregat-Safont D, Gomez-Gomez A, Olesti E, Mason NL, Ramaekers JG Europe PMC Published psilocybin PharmacologyMechanism of ActionConsciousness Review Article More
Select for export LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7196/samj.2023.v113i11.814 PubMed 38525640 Copy citation Copy BibTeX Unknown journal 2023-11-05 Van Der Walt J, Parker R. Europe PMC Published psilocybin DepressionChronic PainMechanism of Action Review Article More
Select for export Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.drudis.2023.103818 PubMed 37925136 Copy citation Copy BibTeX Unknown journal 2023-11-01 Rhee TG, Davoudian PA, Sanacora G, Wilkinson ST. Europe PMC Published psilocybin Clinical TrialReview ArticleSafety Clinical Trial More
Select for export The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231199112 PubMed 37905369 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-10-30 Kurt Stocker, Matthias Hartmann, Laura Ley, A. Becker, Friederike Holze, Matthias E. Liechti OpenAlex Published psilocybin AnxietyConsciousnessMystical Experience Other More
Select for export Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00210-023-02778-x PubMed 37874338 Copy citation Copy BibTeX Unknown journal 2023-10-23 Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H Europe PMC Published psilocybinpsilocin DepressionAnxietyReceptor Pharmacology Animal Study More
Select for export Cardiovascular safety of psychedelic medicine: current status and future directions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s43440-023-00539-4 PubMed 37874530 Copy citation Copy BibTeX Unknown journal 2023-10-23 Wsół A. Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231205692 PubMed 37842884 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-10-15 Natalia Malikowska-Racia, Maciej Koniewski, Joanna Gołębiowska, Piotr Popik OpenAlex Published psilocybin AnxietyChronic PainPharmacology Animal Study More
Select for export An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1) Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s40814-023-01399-8 PubMed 37798662 Copy citation Copy BibTeX Pilot and Feasibility Studies 2023-10-04 C Donegan, Dimitri Daldegan-Bueno, Rachael L. Sumner, David B Menkes, William J. Evans, Nicholas Hoeh OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Randomized Controlled Trial More
Select for export Psychedelics as Therapeutics: Research Advances and Implications for Practice No abstract availability was recorded for this entry. Details DOI 10.1016/j.jaac.2023.07.1001 Copy citation Copy BibTeX Journal of the American Academy of Child & Adolescent Psychiatry 2023-09-30 Kevin M. Gray, Paul E. Croarkin OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Use of Psychedelics for Pain: A Scoping Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/aln.0000000000004673 PubMed 37698433 Copy citation Copy BibTeX Unknown journal 2023-09-30 Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H Europe PMC Published psilocybin AddictionChronic PainHeadache / Migraine Clinical Trial More
Select for export Neuroimaging in psychedelic drug development: past, present, and future. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-023-02271-0 PubMed 37759038 Copy citation Copy BibTeX Unknown journal 2023-09-26 Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D. Europe PMC Published psilocybin DepressionPTSDAddiction Clinical Trial More
Select for export A suite of engineered mice for interrogating psychedelic drug actions Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2023.09.25.559347 Copy citation Copy BibTeX bioRxiv 2023-09-25 Chiu Y, Deutch AY, Wang W, Schmitz GP, Huang KL, Kocak DD bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyPTSD Animal Study More
Select for export Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.ajp-rj.2023.190103 Copy citation Copy BibTeX American Journal of Psychiatry Residents Journal 2023-09-07 Lawrence Canale, Dhvanit Raval, Preet Chatha, Katie Penn, Claudia Weber, Catherine Stout OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Clinical Trial More
Select for export Psychedelics for treatment resistant depression: are they game changers? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14656566.2023.2281582 PubMed 37947195 Copy citation Copy BibTeX Unknown journal 2023-08-31 Kalfas M, Taylor RH, Tsapekos D, Young AH. Europe PMC Published psilocybin DepressionPTSDMechanism of Action Randomized Controlled Trial More
Select for export Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2023.2253538 PubMed 37650700 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2023-08-30 Alexsandra Kovacevich, Jeremy Weleff, Benjamin Claytor, Brian S. Barnett OpenAlex Published psilocybin NeuroplasticityMechanism of ActionReceptor Pharmacology Other More
Select for export The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/jat.4533 PubMed 37646119 Copy citation Copy BibTeX Journal of Applied Toxicology 2023-08-29 Natália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet, Dean Calhoun OpenAlex Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export Pharmacology and Therapeutic Effects of Psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.54097/hset.v65i.11331 Copy citation Copy BibTeX Highlights in Science Engineering and Technology 2023-08-28 Xuehan Du OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2023.2251133 PubMed 37615379 Copy citation Copy BibTeX Unknown journal 2023-08-23 Wong S, Yu AY, Fabiano N, Finkelstein O, Pasricha A, Jones BDM Europe PMC Published psilocybin AnxietyAddictionReceptor Pharmacology Review Article More
Select for export Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-023-40856-5 PubMed 37608057 Copy citation Copy BibTeX Scientific Reports 2023-08-21 Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, Austin J. Mallard, Daniel E. Roberts, David Erritzøe OpenAlex Published psilocybin Receptor PharmacologyMystical ExperienceSafety Other More
Select for export Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2023.00264 Copy citation Copy BibTeX Journal of Psychedelic Studies 2023-08-20 Benjamin M. Ross, James T. Neill OpenAlex Published psilocybin AnxietyReceptor PharmacologyPersonality Change Observational Study More
